V
Veracyte
Biotech & Life Sciences · San Francisco, United States · Founded 2008 · IPO 2013
Talent graph
Veracyte's talent
Source: Dealroom Talent Intelligence.
Veracyte mafia
Startups founded by Veracyte alumni
Former Veracyte employees who went on to start their own companies. Sorted by Dealroom signal score.
Bonnie AndersonUnited States
Jochen KummUnited States
Diana AbduevaUnited States
Jonathan RomanowskyUnited States
Matthew CapizziUnited StatesGlobal footprint
Where Veracyte has talent and traffic
team presence
across markets
Patent intelligence
$38M patent portfolio · 34 active families
Where Veracyte concentrates vs peers
Each axis is a top-10 topic across Veracyte and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Capital deployed
Veracyte's 4 investments and acquisitions.
Every disclosed deal where Veracyte appeared as a backer or acquirer, 2014–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
4 deals across Veracyte's capital deployment.
Where the deals concentrate by sector, stage, and decade.
02 · Portfolio market map
Veracyte's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Veracyte
An AI-synthesized read of the highest-engagement posts about Veracyte on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Veracyte on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.